Frontlight ResearchEarly access
TerminatedNo phase
Adult MDW Dual Cut-Off Accuracy Study
Key facts
- Who runs it
- Beckman Coulter, Inc.
- Where
- Detroit, Hackensack, Indianapolis, and Kansas City, United StatesSee the 5 sites
- Trial code
- Status
- Terminated
- People taking part
- 524 people enrolled
- Started
- 12 Jun 2025
- Ended
- 8 Jul 2026
- Type of study
- Observational
- Treatments tested
- Complete Blood Count with differential
- Record updated
- 31 August 2026
- Why it stopped
- The study was discontinued due to a change in the company's strategic priorities for its hematology platform and was not related to concerns regarding the clinical performance, validity, or safety of MDW.
Who can take part
- Age
- 18 years to 89 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Adults (18 to 89 years) of all races and ethnicities presenting to the ED
- Whole Blood venous samples collected in K2EDTA while the patient was in the ED
- First CBC w/diff test ordered within 12 hours of presentation to ED as part of their standard medical care
- CBC w/diff tested within 2 hours of specimen collection
- Subjects with at least ≥12 hours of follow-up in the ED (or inpatient, if admitted) from presentation
Who cannot take part
- Subjects previously enrolled in this study (i.e. subjects may not be enrolled more than once in this study)
- Subjects' data collected with Instrument Quality Control failure(s)
- CBC w/diff test ordered after 12 hours of presentation to ED
- Subjects discharged from ED <12 hours from ED presentation
- ED Transfer Patients; Data Exclusions Post Enrollment:
- Samples that have a system generated flag from the Standard of Care (SOC) CBC w/diff testing will be excluded
- Samples with instrument flags, including vote outs and review flags for MDW will also be excluded (i.e. invalid MDW results)
Where in United States
- Henry Ford Health SystemDetroit, United States
- Hackensack University Medical CenterHackensack, United States
- Indiana UniversityIndianapolis, United States
- Kansas University Medical CenterKansas City, United States
- Truman Medical CenterKansas City, United States
About the trial
What the trial wants to find out
This study will establish the clinical performance of the Monocyte Distribution Width (MDW) parameter on the DxH 900/ DxH 690T hematology analyzers to aid in the detection and risk assessment of patients in the Emergency Department (ED) for progression to sepsis.
The group in the trial
- Adults presenting to Emergency Department
All-comers study of adults (18 to 89 years) of all races and ethnicities presenting to the Emergency Department
Treatment: Complete Blood Count with differential
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- UniCel DxH 900/690T Monocyte Distribution Width (MDW) Dual Cut-Off Clinical Accuracy Protocol
- Record updated
- 31 August 2026